Video

Q&A with Mitchell Smith: The Merits of Ten Year Followup

Author(s):

Mitchell Smith, MD, Cleveland Clinic shared highlights of his team's posters and discussed the progression of immunotherapies at the 57th American Society of Hematology Annual Meeting.

Mitchell Smith, MD, Cleveland Clinic shared highlights of his team's posters and discussed the progression of immunotherapies at the 57th American Society of Hematology Annual Meeting.

According to Smith, "While response rates aren't as high as we like, and they're not durable in everyone, you can see on the horizon advances in the cell technology and in patient selection."

Related Videos
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Nathan D. Wong, MD, PhD: Growing Role of Lp(a) in Cardiovascular Risk Assessment | Image Credit: UC Irvine
Laurence Sperling, MD: Expanding Cardiologists' Role in Obesity Management  | Image Credit: Emory University
Laurence Sperling, MD: Multidisciplinary Strategies to Combat Obesity Epidemic | Image Credit: Emory University
Schafer Boeder, MD: Role of SGLT2 Inhibitors and GLP-1s in Type 1 Diabetes | Image Credit: UC San Diego
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Alice Cheng, MD: Exploring the Link Between Diabetes and Dementia | Image Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.